Zobrazeno 1 - 10
of 239
pro vyhledávání: '"T. Mittendorf"'
Autor:
Matthias Stoll, Johannes R. Bogner, J. van Lunzen, B. Ranneberg, W. Schmidt, M. Hower, T. Mittendorf, C. Bachmann, H. Heiken, Olaf Degen, S. Gerschmann, I. Leistner, S. Klauke, Alexander Kuhlmann, T. Lutz, Hans-Jürgen Stellbrink, Jörg Mahlich
Publikováno v:
Das Gesundheitswesen. 77:e133-e142
Hintergrund: Die Einfuhrung der hochaktiven kombinierten antiretroviralen Therapie (c-ART) bewirkte eine signifikante Senkung von Mortalitat und Morbiditat fur HIV-positive Patienten. Fruhere gesundheitsokonomische Studien zeigten, dass die damit ver
Publikováno v:
Value in Health. 22:S789
Autor:
Norbert Marschner, Sebastian Braun, A. Sauer, T. Mittendorf, Christian Jacob, J Altevers, Wolfgang Greiner, E. Eggers, M Jaenicke, N. Wetzel, K. Borchert
Publikováno v:
Value in Health. 22:S529
Publikováno v:
Value in Health. 22:S501
Autor:
M. Isernia, M. Konstanski, U. Kuchenbecker, D. Lidonnici, M. Morichi, T. Mittendorf, G. Casilli, EP Lanati
Publikováno v:
Value in Health. 22:S719
Publikováno v:
Value in Health. 22:S811
Publikováno v:
PharmacoEconomics German Research Articles. 10:3-15
Background: In Germany, and throughout the world, the lung carcinoma is one of the most common and aggressive forms of cancer. Not only is the diagnosis itself stressful for the patients, but also the disease symptoms, such as (blood) cough, shortnes
Publikováno v:
Pneumologie. 65:498-502
Aim There are only very limited data available on the costs and health-related quality of life (hrQoL) of patients with community-acquired pneumonia (CAP) in Germany. The aim of this review was to identify studies in the international literature rega
Publikováno v:
Value in Health. 21:S331
Publikováno v:
PharmacoEconomics German Research Articles. 8:21-29
Background Schizophrenia entails a high cost burden to payers in many healthcare systems across the world. In Germany, direct costs of schizophrenia and other delusional disorders came to € 2.7 billion within the statutory healthcare system in 2006